Heberprot-P is a Cuban medicine for the treatment of diabetic foot ulcers and this medicine is available in more than 10 countries. Currently, this medicine is not available legally in the United States, but it is under testing process.
South Korean scientists have developed a transparent skin patch that tests glucose levels in perspiration (instead of blood) and simultaneously injects drugs through microneedles. Sensors in the patch can send the data collected from perspiration to Smartphone App. A need of medication will be checked by App and instruct microneedles in the patch to deliver drugs. Trials on mice and couple of humans were successful and more tests are going to be conducted under challenging conditions. If the prototype is successful, then the patch could be available within a few years. It is expected that the cost of the patch is same as the conventional diagnostics and treatment kit.
Dr. Melissa Schilling, Professor at NYU Stern School of Business have found a connection between diabetes and Alzheimer's disease. She found hyperinsulinemia is responsible for almost half of Alzheimer's cases. Hyperinsulinemia is a condition where excess levels of insulin are being circulated in the body. Her finding was published by The Journal of Alzheimer's Disease.
Researchers analyzed 2,525 participants between 40 to 69 years for four-and-a-half years and found that depression combined with risks of developing diabetes will have a greater risk of developing type 2 diabetes. Results published in the journal Molecular Psychiatry.
The Salk Scientists announced a cure to diabetes. Scientists found ERR-gamma protein switch that makes lab-grown cells more responsive to glucose and makes them release insulin at a normal rate. Scientists have checked the new technology on mice with type 1 diabetes (T1D) by transplanting mature lab-grown beta cells with ERR gamma protein switch on. Half of the diabetic mice showed normal glucose levels within 2 months. If this technology is successful, one day it is possible to grow insulin producing beta cells from pluripotent stem cells taken from the patients. This technology is more practical, applicable and affordable to the mass market. This research was published in the journal Cell Metabolism.
Researchers examined patients with liver diseases for over 10 years and concluded that people with type 2 diabetes (T2D) may have a greater liver risk (3 times more) compared with those without type 2 diabetes. The reason for liver disease in diabetes patients is due to the buildup of fat within liver cells. The buildup of fat within liver cells is called non-alcoholic fatty liver disease (NAFLD). People can avoid NAFLD by following a proper diet. The team involves researchers from universities of Southampton and Edinburgh.
National Center for Global Health and Medicine, Tokyo, hopes to transplant insulin producing cells of pigs into humans to cure type 1 diabetes (T1D) as the Japan government relaxed rules. They want to do this within 3 years.
The most obese citizen's state in the United States is Mississippi. As obesity of the citizens is high, diabetes health care costs ($10,507, 4Th highest) and premature deaths (487 per 10,000) are too high. Incidentally, nine of the ten most obese states are in the south.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.